Zdrowie i gospodarka · 10/10/2018
FDA Announces Revised Draft Guidance for Evaluating Adhesion of Transdermal and Topical Delivery Systems for ANDAs
The FDA has released a revised draft guidance for industry on assessing adhesion with transdermal and topical delivery systems for abbreviated new drug applications (ANDAs), replacing a previous version announced in 2016